Pain management · 2026
Repeated virtual reality sessions in fibromyalgia: a prospective observational study.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Amodeo Jean-Marie, Berthier Frederic, Biehlmann Cindy, Piazza Brigitte
Аннотация
AIMS: Fibromyalgia (FM) is a chronic pain syndrome with limited effective treatments. This study evaluated virtual reality (VR) as an adjunct therapy.
METHODS: Participants used the HealthyMind program delivered via a Pico G2 4K Enterprise headset in eight supervised, seated 20-minute sessions over four weeks, featuring nature relaxation, guided imagery, and meditation. Primary outcome was Pain Numerical Rating Scale (NRS) at one month (M1); secondary outcomes included PCS, PSEQ, and HADS.
RESULTS: Fifty participants completed baseline and M1 assessments. Pain significantly decreased from 6.8 ± 1.5 to 5.8 ± 1.9 (-14.8%, p < 0.001; effect size = 0.56). Significant improvements were observed in catastrophizing, self-efficacy, anxiety, and depression.
CONCLUSION: Repeated HealthyMind VR use was associated with reduced pain and improved psychological outcomes in FM patients.
CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov identifier is (NCT05567861).
METHODS: Participants used the HealthyMind program delivered via a Pico G2 4K Enterprise headset in eight supervised, seated 20-minute sessions over four weeks, featuring nature relaxation, guided imagery, and meditation. Primary outcome was Pain Numerical Rating Scale (NRS) at one month (M1); secondary outcomes included PCS, PSEQ, and HADS.
RESULTS: Fifty participants completed baseline and M1 assessments. Pain significantly decreased from 6.8 ± 1.5 to 5.8 ± 1.9 (-14.8%, p < 0.001; effect size = 0.56). Significant improvements were observed in catastrophizing, self-efficacy, anxiety, and depression.
CONCLUSION: Repeated HealthyMind VR use was associated with reduced pain and improved psychological outcomes in FM patients.
CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov identifier is (NCT05567861).